US 12,728,190 B2
CSF diagnostics platform
Rajan Patel, Newburyport, MA (US); Gianna N. Riccardi, South Berwick, ME (US); Kevin Kalish, Newburyport, MA (US); and Marcie Glicksman, Salem, MA (US)
Assigned to EnClear Therapies, Inc., Newburyport, MA (US)
Filed by EnClear Therapies, Inc., Newburyport, MA (US)
Filed on Jul. 19, 2022, as Appl. No. 17/868,484.
Application 17/868,484 is a continuation in part of application No. 17/848,211, filed on Jun. 23, 2022.
Application 17/848,211 is a continuation in part of application No. 17/669,883, filed on Feb. 11, 2022, granted, now 12,350,416.
Application 17/848,211 is a continuation in part of application No. 17/495,682, filed on Oct. 6, 2021.
Application 17/848,211 is a continuation in part of application No. 17/489,620, filed on Sep. 29, 2021, granted, now 12,337,140.
Application 17/669,883 is a continuation of application No. 17/062,440, filed on Oct. 2, 2020, granted, now 11,278,657, issued on Mar. 22, 2022.
Application 17/062,440 is a continuation of application No. PCT/US2020/027683, filed on Apr. 10, 2020.
Claims priority of provisional application 63/223,248, filed on Jul. 19, 2021.
Claims priority of provisional application 63/214,239, filed on Jun. 23, 2021.
Claims priority of provisional application 63/117,975, filed on Nov. 24, 2020.
Claims priority of provisional application 63/088,401, filed on Oct. 6, 2020.
Claims priority of provisional application 63/084,996, filed on Sep. 29, 2020.
Claims priority of provisional application 62/960,861, filed on Jan. 14, 2020.
Claims priority of provisional application 62/832,486, filed on Apr. 11, 2019.
Prior Publication US 2022/0355015 A1, Nov. 10, 2022
Int. Cl. A61M 1/36 (2006.01); A61M 1/16 (2006.01); A61M 27/00 (2006.01)
CPC A61M 1/3687 (2013.01) [A61M 1/16 (2013.01); A61M 1/1601 (2014.02); A61M 27/006 (2013.01); A61M 1/3655 (2013.01); A61M 1/3659 (2014.02); A61M 2027/004 (2013.01); A61M 2202/0464 (2013.01); A61M 2205/103 (2013.01); A61M 2205/12 (2013.01); A61M 2205/3334 (2013.01); A61M 2205/3344 (2013.01); A61M 2205/3379 (2013.01); A61M 2210/1003 (2013.01); A61M 2210/1039 (2013.01)] 39 Claims
OG exemplary drawing
 
1. A CSF management method for use with a patient having a body with CSF, the method comprising:
forming a CSF circuit having at least one pump and catheter, the CSF circuit configured to channel the flow of the patient's CSF;
adding a therapeutic material to the CSF circuit;
flowing, using the pump and the catheter, the patient's CSF through the CSF circuit at one or more flow rates;
monitoring, when CSF is flowing in the CSF circuit, at least one quality of the CSF related to the therapeutic material, the at least one quality including a concentration of the therapeutic material in the CSF, after adding the therapeutic material to the CSF; and
controlling the one or more flow rates of the CSF as a function of a monitored concentration of the therapeutic material in the CSF to control absorption or distribution of the therapeutic material.